Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Japanese Clinical Practice Guideline for Diabetes 2019.
Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Araki E, et al. Among authors: tanizawa y. Diabetol Int. 2020 Jul 24;11(3):165-223. doi: 10.1007/s13340-020-00439-5. eCollection 2020 Jul. Diabetol Int. 2020. PMID: 32802702 Free PMC article. Review. No abstract available.
Japanese Clinical Practice Guideline for Diabetes 2019.
Araki E, Goto A, Kondo T, Noda M, Noto H, Origasa H, Osawa H, Taguchi A, Tanizawa Y, Tobe K, Yoshioka N. Araki E, et al. Among authors: tanizawa y. J Diabetes Investig. 2020 Jul;11(4):1020-1076. doi: 10.1111/jdi.13306. J Diabetes Investig. 2020. PMID: 33021749 Free PMC article. No abstract available.
Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society.
Araki E, Tanaka A, Inagaki N, Ito H, Ueki K, Murohara T, Imai K, Sata M, Sugiyama T, Ishii H, Yamane S, Kadowaki T, Komuro I, Node K; directors of the JCS, JDS. Araki E, et al. Diabetol Int. 2020 Nov 30;12(1):1-51. doi: 10.1007/s13340-020-00471-5. eCollection 2021 Jan. Diabetol Int. 2020. PMID: 33479578 Free PMC article. No abstract available.
Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trials.
Tanizawa Y, Kaku K, Araki E, Tobe K, Terauchi Y, Utsunomiya K, Iwamoto Y, Watada H, Ohtsuka W, Watanabe D, Suganami H; Tofogliflozin 004 and 005 Study group. Tanizawa Y, et al. Expert Opin Pharmacother. 2014 Apr;15(6):749-66. doi: 10.1517/14656566.2014.887680. Epub 2014 Feb 11. Expert Opin Pharmacother. 2014. PMID: 24512053 Clinical Trial.
Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001-2010: Report of the Committee on Causes of Death in Diabetes Mellitus.
Nakamura J, Kamiya H, Haneda M, Inagaki N, Tanizawa Y, Araki E, Ueki K, Nakayama T. Nakamura J, et al. Among authors: tanizawa y. J Diabetes Investig. 2017 May;8(3):397-410. doi: 10.1111/jdi.12645. Epub 2017 Mar 27. J Diabetes Investig. 2017. PMID: 28349643 Free PMC article.
Molecular clock as a regulator of β-cell function.
Taguchi A, Ohta Y, Tanizawa Y. Taguchi A, et al. Among authors: tanizawa y. J Diabetes Investig. 2018 Mar 15;9(3):453-6. doi: 10.1111/jdi.12835. Online ahead of print. J Diabetes Investig. 2018. PMID: 29544027 Free PMC article.
395 results